BRPI0807981A2 - Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso - Google Patents

Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso

Info

Publication number
BRPI0807981A2
BRPI0807981A2 BRPI0807981-1A2A BRPI0807981A BRPI0807981A2 BR PI0807981 A2 BRPI0807981 A2 BR PI0807981A2 BR PI0807981 A BRPI0807981 A BR PI0807981A BR PI0807981 A2 BRPI0807981 A2 BR PI0807981A2
Authority
BR
Brazil
Prior art keywords
biotine
biotin
derivative
understanding
molecular weight
Prior art date
Application number
BRPI0807981-1A2A
Other languages
English (en)
Inventor
Philippe Hubert
Pierre Mourier
Christian Viskov
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BRPI0807981A2 publication Critical patent/BRPI0807981A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BRPI0807981-1A2A 2007-02-14 2008-02-12 Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso BRPI0807981A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0701055A FR2912409B1 (fr) 2007-02-14 2007-02-14 Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
PCT/FR2008/000173 WO2008113919A1 (fr) 2007-02-14 2008-02-12 Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
BRPI0807981A2 true BRPI0807981A2 (pt) 2014-06-24

Family

ID=38461986

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807981-1A2A BRPI0807981A2 (pt) 2007-02-14 2008-02-12 Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso

Country Status (15)

Country Link
US (1) US20100081629A1 (pt)
EP (1) EP2121769A1 (pt)
JP (1) JP5351770B2 (pt)
KR (1) KR20090109104A (pt)
CN (1) CN101636417A (pt)
AR (1) AR065323A1 (pt)
AU (1) AU2008228162A1 (pt)
BR (1) BRPI0807981A2 (pt)
CA (1) CA2678168A1 (pt)
FR (1) FR2912409B1 (pt)
IL (1) IL200111A0 (pt)
MX (1) MX2009008752A (pt)
RU (1) RU2009134188A (pt)
TW (1) TW200846014A (pt)
WO (1) WO2008113919A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2584927T7 (es) 2007-10-16 2020-11-05 Progen Pg500 Series Pty Ltd Derivados de oligosacáridos sulfatados novedosos
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
CN103421128B (zh) * 2013-07-31 2015-08-12 山东辰中生物制药有限公司 一种高品质低分子帕那肝素的制备方法
EP3388439A1 (en) * 2017-04-11 2018-10-17 Leadiant Biosciences SA Biotin-conjugated n-acetyl glycol split heparin
CN111333664A (zh) * 2020-03-27 2020-06-26 苏州昊帆生物股份有限公司 生物素交联剂、应用及其制备方法
CN117777216A (zh) * 2022-09-21 2024-03-29 中国科学院上海药物研究所 可中和的生物素化肝素五糖的制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38743E1 (en) * 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
IL200111A0 (en) 2010-04-15
US20100081629A1 (en) 2010-04-01
CA2678168A1 (fr) 2008-09-25
RU2009134188A (ru) 2011-03-20
JP5351770B2 (ja) 2013-11-27
AU2008228162A1 (en) 2008-09-25
KR20090109104A (ko) 2009-10-19
TW200846014A (en) 2008-12-01
MX2009008752A (es) 2009-08-27
FR2912409A1 (fr) 2008-08-15
JP2010518238A (ja) 2010-05-27
AR065323A1 (es) 2009-05-27
WO2008113919A1 (fr) 2008-09-25
EP2121769A1 (fr) 2009-11-25
CN101636417A (zh) 2010-01-27
FR2912409B1 (fr) 2012-08-24

Similar Documents

Publication Publication Date Title
AR065323A1 (es) Heparinas de bajo peso molecular que comprenden al menos un enlace covalente con la biotina o un derivado de la biotina , su procedimiento de preparacion y su utilizacion
BRPI0912923A2 (pt) composto que consiste de um oligonucleotídeo modificadpo composto de 12-30 nucleosídeos ligados, compostos que compreende um oligonucleotídeo modificado que compreende pelo menos 12 nucleosídeos ligados, composto que compreende um oligonucleotídeo modificado que compreende nucleosídeos ligados, e, uso de um composto
MX2008008152A (es) Compuestos heterociclicos biciclicos.
BRPI0812819A2 (pt) Artigos de fumar com características de propensão de ignição reduzida
BRPI0722088A2 (pt) derivados de pirrolo[2,3-b]piridina como moduladores de cinase
EP4386013C0 (en) SODIUM HYALURONATE WITH COMPLETE MOLECULAR MASS DISTRIBUTION, ITS PREPARATION PROCESS AND ITS USE
HUE038855T2 (hu) Kis molekulatömegû sziloxánok egy funkciós csoporttal
BRPI0817265A2 (pt) Vacina de rna, uso de pelo menos uma molécula de rna, e, molécula de rna isolada
IL202039A0 (en) Florene, anthracene, xanthene, dibenzosuberone and acridine derivatives, compositions comprising the same and uses thereof
IL194813A0 (en) Triazolopyrazine derivatives useful as anti-cancer agents
BRPI0515328A (pt) composições hidráulicas flexìveis
BRPI0716175A2 (pt) Artigos absorventes compreendendo polímeros superabsorventes com propriedades superiores.
FR2912906B1 (fr) Composition de coloration comprenant au moins un colorant azoique cotionique a motif julolidine et au moins un compose non polymerique a chaine hydrophobe et procede de coloration
BRPI0811621A2 (pt) Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição
WO2007144709A3 (en) Leptomycin derivatives
FR2897132B3 (fr) Plaque de maillon de chaine de haute robustesse
WO2010023670A3 (en) Methods for covalently attaching a polymer to a methionine residue in proteins and peptides
WO2007080325A8 (fr) Composes dimeres agonistes des recepteurs des fgfs
WO2009018112A3 (en) The use of novel coumarins as glutathione and thiol labels
WO2009105042A8 (en) Thienothiophene derivatives
DK1948561T3 (da) Multi-substitueret hydroxyapatit og sammensætning deraf med en naturlig og/eller syntetisk polymer, fremstilling og anvendelser deraf
BRPI0702173A2 (pt) estufa e mÉtodo para cura de folhas de fumo
BRPI0920258A2 (pt) composição, processo para fabricar composição, processo para fabricar um polímero de pelo menos um éster acrílico, artigo ou parte de artigo, e, uso da composição
FR2922885B1 (fr) Fils de verre a faible teneur en alumine aptes a renforcer des matieres organiques et/ou inorganiques.
WO2008107912A3 (en) In vitro assay methods for classifying embryotoxicity of compounds

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.